Salesforce Lifts FY22 Revenue Outlook, Issues FY23 View

Salesforce Lifts FY22 Revenue Outlook, Issues FY23 View
September 24, 2021

Video Source: CNBC Television on YouTube

 

Customer relationship management solution provider Salesforce.Com Inc (NYSE: CRM) upwardly revised its FY 2022 revenue outlook and also issued revenue guidance for the fiscal year 2023. Furthermore, the company also initiated FY 2023 GAAP operating margin and non-GAAP operating margin guidance. Following the robust revenue outlook, the stock gained 7.21% or $18.69 to close Thursday’s trading session at $277.86.

The San Francisco, California-based company now expects full-year 2022 revenues of between $26.25 billion and $26.35 billion. Earlier, the company had issued FY 2022 revenue outlook in the range of $26.20 billion to $26.30 billion. Analysts surveyed by Refinitiv anticipate revenues of $26.31 billion.

For fiscal 2023, the cloud-based enterprise software solution provider forecasts revenues between $31.65 billion and $31.80 billion. The consensus estimate calls for revenues of $31.47 billion.

The company also forecasts FY 2023 GAAP operating margin of between 3% and 3.5%. Furthermore, the non-GAAP operating margin is projected to be 20%.

For the third quarter of fiscal 2022, analysts anticipate adjusted earnings of $0.92 per share on revenues of $6.80 billion. Likewise, for the fourth quarter of fiscal 2022, analysts anticipate the company to forecast earnings of $0.82 per share on revenues of $7.21 billion.

Notably, the company reported better-than-anticipated results for 2Q 2022. Specifically, Salesforce posted Q2 revenues of $6.34 billion, an increase of 23% on a y-o-y basis, exceeding Wall Street estimates of $6.23 billion. Also, the second-quarter adjusted earnings of $1.48 per share eclipsed Zacks Consensus estimate of $0.91 per share. The reported earnings reflect a 3% y-o-y increase, aided by solid topline growth and gains of $0.43 per share from strategic investments.

While subscription revenues rose by 22% y-o-y to $5.91 billion, professional services and other revenues increased 37% to $426 million. Salesforce ended the quarter with cash, cash equivalents, and marketable securities worth $9.65 billion, down from $15.02 billion at the end of the prior quarter.

The company benefited from a solid demand environment as clients went through a key digital transformation. The quick adoption of its cloud-based offerings enabled the company to post impressive results in the second quarter.

The upward revision of the FY 2022 revenue outlook and robust FY 2023 guidance is expected to keep the stock bullish in the short term.

Technically, the stock has firmly broken above the ascending triangle, as shown in the image below. Additionally, the stock is trading above its 50-day moving average. The Chaikin money flow indicator also has a positive reading. Therefore, we are anticipating the stock to remain in an uptrend in the short term.

crm - technical analysis - 24 September 2021

Disclaimer: Any financial trading analysis offered here is our opinion and is not intended as advice or direction for investors. We cannot guarantee the success of any trades made as a consequence of this article, and we encourage traders to incorporate a strong money management strategy to limit losses when they enter the markets. Please use this article as part of your own research before formulating strategies prior to trading.

Andrew Wright

Prior to founding tradersasset.com in 2014, Andrew worked as a proprietary trader, then as a market maker. As a market maker, he traded options in over 100 stocks, he then began trading currency pairs in 2013. Andrew still actively trades both, and prides himself on educating and informing traders on the benefits of both Binary Options and Forex.


Related Articles

ADP’s Q4 EPS Tops Estimates, Issues Upbeat FY17 Outlook

The shares of Automatic Data Processing Inc. (Nasdaq: ADP) declined to $88.67 on Monday, following the announcement of fiscal 2016

ANTA Sports To Acquire Amer Sports For €4.6 billion

  China’s ANTA Sports Products Limited (OTC: ANPDY) is leading a consortium that is in the final stages of agreeing

FDA Allows Pharmacists to Prescribe Pfizer’s COVID-19 Pill

Video Source: ABC News on YouTube   Pfizer Inc. (NYSE: PFE) grabbed the market’s attention yesterday after the US FDA